Job offer: PhD in Blood-brain barrier dysfunction and oxidative stress modulation in brain arteriovenous malformations

A pre-doctoral position in molecular imaging neurosciences is offered to work on a collaborative and interdisciplinary project between the Neuroimaging and Biomarkers of Inflammation Group, led by Dr. Abraham Martín and the Radiochemistry and Nuclear Imaging Group, led by Dr. Jordi Llop at CIC biomaGUNE.

The selected candidate will participate in a translational project funded by The Foundation-La Marató de TV3, and aimed to investigate the blood-brain barrier dysfunction an oxidative stress modulation in brain arteriovenous malformations (AVMs). The project will use tools to mimic AVMs in rats and a battery of in vivo molecular imaging techniques (positron emission tomography –PET–, Magnetic resonance imaging –MRI–) together with ex vivo molecular biology, and immunohistochemical techniques to decipher the negative effect of AVMs at different molecular, cellular and tissue levels.

We highly value motivation, creativity, imagination, and abilities team-work capacity. Both ACHUCARRO and CIC biomaGUNE offer good conditions and an excellent research environment and facilities.

Summary Information

Application Deadline: February 28th 2021
Profile of candidates:
  • Excellent academic record (> 7.5).
  • Graduate and Master degree in Biomedical or Life sciences and related areas.
  • Solid communication skills in English
What we offer:
  • 1-year contract with the possibility of extension
  • Support for PhD fellowship applications
  • Interdisciplinary training in a team with a strong background in Glial Neurobiology

How to Apply

Candidates should submit a motivation letter, CV, academic record and, at least, one letter of reference to Dr. Abraham Martín, indicating "AVM _PhD" in the subject.

Achucarro commits to the principles laid down in the European Commission's Recommendation (March 11, 2005) for the European Charter for Researchers (The Code of Conduct for the Recruitment of Researchers). See our statement on Open, Transparent and Merit-based Recruitment.